Lee ES, Locker J, Nalesnik M, Reyes J, Jaffe R, Alashari M, Nour B, Tzakis A, Dickman PS (January 1995). “The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation”. 《N. Engl. J. Med.》 332 (1): 19–25. doi:10.1056/NEJM199501053320104. PMID7990861.
Ambrosi D, Mollica F (2002). “On the mechanics of a growing tumor”. 《International Journal of Engineering Science》 40 (12): 1297–316. doi:10.1016/S0020-7225(02)00014-9.
Kastan MB (2008). “DNA damage responses: mechanisms and roles in human disease: 2007 G.H.A. Clowes Memorial Award Lecture”. 《Mol. Cancer Res.》 6 (4): 517–24. doi:10.1158/1541-7786.MCR-08-0020. PMID18403632.
Cunningham FH, Fiebelkorn S, Johnson M, Meredith C (November 2011). “A novel application of the Margin of Exposure approach: segregation of tobacco smoke toxicants”. 《Food Chem. Toxicol.》 49 (11): 2921–33. doi:10.1016/j.fct.2011.07.019. PMID21802474.
Kanavy HE, Gerstenblith MR (December 2011). “Ultraviolet radiation and melanoma”. 《Semin Cutan Med Surg》 30 (4): 222–8. doi:10.1016/j.sder.2011.08.003. PMID22123420.
Katsurano M, Niwa T, Yasui Y, Shigematsu Y, Yamashita S, Takeshima H, Lee MS, Kim YJ, Tanaka T, Ushijima T (January 2012). “Early-stage formation of an epigenetic field defect in a mouse colitis model, and non-essential roles of T- and B-cells in DNA methylation induction”. 《Oncogene》 31 (3): 342–51. doi:10.1038/onc.2011.241. PMID21685942.
Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K (July 2000). “Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland”. 《N. Engl. J. Med.》 343 (2): 78–85. doi:10.1056/NEJM200007133430201. PMID10891514.
Lee KH, Lee JS, Nam JH, Choi C, Lee MC, Park CS, Juhng SW, Lee JH (October 2011). “Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence”. 《Langenbecks Arch Surg》 396 (7): 1017–26. doi:10.1007/s00423-011-0812-9. PMID21706233. S2CID8069716.
Amatu A, Sartore-Bianchi A, Moutinho C, Belotti A, Bencardino K, Chirico G, Cassingena A, Rusconi F, Esposito A, Nichelatti M, Esteller M, Siena S (April 2013). “Promoter CpG island hypermethylation of the DNA repair enzyme MGMT predicts clinical response to dacarbazine in a phase II study for metastatic colorectal cancer”. 《Clin. Cancer Res.》 19 (8): 2265–72. doi:10.1158/1078-0432.CCR-12-3518. PMID23422094.
Mokarram P, Zamani M, Kavousipour S, Naghibalhossaini F, Irajie C, Moradi Sarabi M, 외. (May 2013). “Different patterns of DNA methylation of the two distinct O6-methylguanine-DNA methyltransferase (O6-MGMT) promoter regions in colorectal cancer”. 《Mol. Biol. Rep.》 40 (5): 3851–7. doi:10.1007/s11033-012-2465-3. PMID23271133. S2CID18733871.
Truninger K, Menigatti M, Luz J, Russell A, Haider R, Gebbers JO, 외. (May 2005). “Immunohistochemical analysis reveals high frequency of PMS2 defects in colorectal cancer”. 《Gastroenterology》 128 (5): 1160–71. doi:10.1053/j.gastro.2005.01.056. PMID15887099.
Rubin H (March 2011). “Fields and field cancerization: the preneoplastic origins of cancer: asymptomatic hyperplastic fields are precursors of neoplasia, and their progression to tumors can be tracked by saturation density in culture”. 《BioEssays》 33 (3): 224–31. doi:10.1002/bies.201000067. PMID21254148. S2CID44981539.
Shen L, Kondo Y, Rosner GL, Xiao L, Hernandez NS, Vilaythong J, Houlihan PS, Krouse RS, Prasad AR, Einspahr JG, Buckmeier J, Alberts DS, Hamilton SR, Issa JP (September 2005). “MGMT promoter methylation and field defect in sporadic colorectal cancer”. 《J. Natl. Cancer Inst.》 97 (18): 1330–8. doi:10.1093/jnci/dji275. PMID16174854.
Lee KH, Lee JS, Nam JH, Choi C, Lee MC, Park CS, Juhng SW, Lee JH (October 2011). “Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence”. 《Langenbecks Arch Surg》 396 (7): 1017–26. doi:10.1007/s00423-011-0812-9. PMID21706233. S2CID8069716.
Svrcek M, Buhard O, Colas C, Coulet F, Dumont S, Massaoudi I, 외. (November 2010). “Methylation tolerance due to an O6-methylguanine DNA methyltransferase (MGMT) field defect in the colonic mucosa: an initiating step in the development of mismatch repair-deficient colorectal cancers”. 《Gut》 59 (11): 1516–26. doi:10.1136/gut.2009.194787. PMID20947886. S2CID206950452.
Paluszczak J, Misiak P, Wierzbicka M, Woźniak A, Baer-Dubowska W (February 2011). “Frequent hypermethylation of DAPK, RARbeta, MGMT, RASSF1A and FHIT in laryngeal squamous cell carcinomas and adjacent normal mucosa”. 《Oral Oncol.》 47 (2): 104–7. doi:10.1016/j.oraloncology.2010.11.006. PMID21147548.
Zuo C, Zhang H, Spencer HJ, Vural E, Suen JY, Schichman SA, Smoller BR, Kokoska MS, Fan CY (October 2009). “Increased microsatellite instability and epigenetic inactivation of the hMLH1 gene in head and neck squamous cell carcinoma”. 《Otolaryngol Head Neck Surg》 141 (4): 484–90. doi:10.1016/j.otohns.2009.07.007. PMID19786217. S2CID8357370.
Tawfik HM, El-Maqsoud NM, Hak BH, El-Sherbiny YM (2011). “Head and neck squamous cell carcinoma: mismatch repair immunohistochemistry and promoter hypermethylation of hMLH1 gene”. 《Am J Otolaryngol》 32 (6): 528–36. doi:10.1016/j.amjoto.2010.11.005. PMID21353335.
Zou XP, Zhang B, Zhang XQ, Chen M, Cao J, Liu WJ (November 2009). “Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions”. 《Hum. Pathol.》 40 (11): 1534–42. doi:10.1016/j.humpath.2009.01.029. PMID19695681.
Wani M, Afroze D, Makhdoomi M, Hamid I, Wani B, Bhat G, Wani R, Wani K (2012). “Promoter methylation status of DNA repair gene (hMLH1) in gastric carcinoma patients of the Kashmir valley”. 《Asian Pac. J. Cancer Prev.》 13 (8): 4177–81. doi:10.7314/APJCP.2012.13.8.4177. PMID23098428.
Lee ES, Locker J, Nalesnik M, Reyes J, Jaffe R, Alashari M, Nour B, Tzakis A, Dickman PS (January 1995). “The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation”. 《N. Engl. J. Med.》 332 (1): 19–25. doi:10.1056/NEJM199501053320104. PMID7990861.
Kastan MB (2008). “DNA damage responses: mechanisms and roles in human disease: 2007 G.H.A. Clowes Memorial Award Lecture”. 《Mol. Cancer Res.》 6 (4): 517–24. doi:10.1158/1541-7786.MCR-08-0020. PMID18403632.
Cunningham FH, Fiebelkorn S, Johnson M, Meredith C (November 2011). “A novel application of the Margin of Exposure approach: segregation of tobacco smoke toxicants”. 《Food Chem. Toxicol.》 49 (11): 2921–33. doi:10.1016/j.fct.2011.07.019. PMID21802474.
Kanavy HE, Gerstenblith MR (December 2011). “Ultraviolet radiation and melanoma”. 《Semin Cutan Med Surg》 30 (4): 222–8. doi:10.1016/j.sder.2011.08.003. PMID22123420.
Katsurano M, Niwa T, Yasui Y, Shigematsu Y, Yamashita S, Takeshima H, Lee MS, Kim YJ, Tanaka T, Ushijima T (January 2012). “Early-stage formation of an epigenetic field defect in a mouse colitis model, and non-essential roles of T- and B-cells in DNA methylation induction”. 《Oncogene》 31 (3): 342–51. doi:10.1038/onc.2011.241. PMID21685942.
Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K (July 2000). “Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland”. 《N. Engl. J. Med.》 343 (2): 78–85. doi:10.1056/NEJM200007133430201. PMID10891514.
Lee KH, Lee JS, Nam JH, Choi C, Lee MC, Park CS, Juhng SW, Lee JH (October 2011). “Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence”. 《Langenbecks Arch Surg》 396 (7): 1017–26. doi:10.1007/s00423-011-0812-9. PMID21706233. S2CID8069716.
Amatu A, Sartore-Bianchi A, Moutinho C, Belotti A, Bencardino K, Chirico G, Cassingena A, Rusconi F, Esposito A, Nichelatti M, Esteller M, Siena S (April 2013). “Promoter CpG island hypermethylation of the DNA repair enzyme MGMT predicts clinical response to dacarbazine in a phase II study for metastatic colorectal cancer”. 《Clin. Cancer Res.》 19 (8): 2265–72. doi:10.1158/1078-0432.CCR-12-3518. PMID23422094.
Mokarram P, Zamani M, Kavousipour S, Naghibalhossaini F, Irajie C, Moradi Sarabi M, 외. (May 2013). “Different patterns of DNA methylation of the two distinct O6-methylguanine-DNA methyltransferase (O6-MGMT) promoter regions in colorectal cancer”. 《Mol. Biol. Rep.》 40 (5): 3851–7. doi:10.1007/s11033-012-2465-3. PMID23271133. S2CID18733871.
Truninger K, Menigatti M, Luz J, Russell A, Haider R, Gebbers JO, 외. (May 2005). “Immunohistochemical analysis reveals high frequency of PMS2 defects in colorectal cancer”. 《Gastroenterology》 128 (5): 1160–71. doi:10.1053/j.gastro.2005.01.056. PMID15887099.
Rubin H (March 2011). “Fields and field cancerization: the preneoplastic origins of cancer: asymptomatic hyperplastic fields are precursors of neoplasia, and their progression to tumors can be tracked by saturation density in culture”. 《BioEssays》 33 (3): 224–31. doi:10.1002/bies.201000067. PMID21254148. S2CID44981539.
Shen L, Kondo Y, Rosner GL, Xiao L, Hernandez NS, Vilaythong J, Houlihan PS, Krouse RS, Prasad AR, Einspahr JG, Buckmeier J, Alberts DS, Hamilton SR, Issa JP (September 2005). “MGMT promoter methylation and field defect in sporadic colorectal cancer”. 《J. Natl. Cancer Inst.》 97 (18): 1330–8. doi:10.1093/jnci/dji275. PMID16174854.
Lee KH, Lee JS, Nam JH, Choi C, Lee MC, Park CS, Juhng SW, Lee JH (October 2011). “Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence”. 《Langenbecks Arch Surg》 396 (7): 1017–26. doi:10.1007/s00423-011-0812-9. PMID21706233. S2CID8069716.
Svrcek M, Buhard O, Colas C, Coulet F, Dumont S, Massaoudi I, 외. (November 2010). “Methylation tolerance due to an O6-methylguanine DNA methyltransferase (MGMT) field defect in the colonic mucosa: an initiating step in the development of mismatch repair-deficient colorectal cancers”. 《Gut》 59 (11): 1516–26. doi:10.1136/gut.2009.194787. PMID20947886. S2CID206950452.
Paluszczak J, Misiak P, Wierzbicka M, Woźniak A, Baer-Dubowska W (February 2011). “Frequent hypermethylation of DAPK, RARbeta, MGMT, RASSF1A and FHIT in laryngeal squamous cell carcinomas and adjacent normal mucosa”. 《Oral Oncol.》 47 (2): 104–7. doi:10.1016/j.oraloncology.2010.11.006. PMID21147548.
Zuo C, Zhang H, Spencer HJ, Vural E, Suen JY, Schichman SA, Smoller BR, Kokoska MS, Fan CY (October 2009). “Increased microsatellite instability and epigenetic inactivation of the hMLH1 gene in head and neck squamous cell carcinoma”. 《Otolaryngol Head Neck Surg》 141 (4): 484–90. doi:10.1016/j.otohns.2009.07.007. PMID19786217. S2CID8357370.
Tawfik HM, El-Maqsoud NM, Hak BH, El-Sherbiny YM (2011). “Head and neck squamous cell carcinoma: mismatch repair immunohistochemistry and promoter hypermethylation of hMLH1 gene”. 《Am J Otolaryngol》 32 (6): 528–36. doi:10.1016/j.amjoto.2010.11.005. PMID21353335.
Zou XP, Zhang B, Zhang XQ, Chen M, Cao J, Liu WJ (November 2009). “Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions”. 《Hum. Pathol.》 40 (11): 1534–42. doi:10.1016/j.humpath.2009.01.029. PMID19695681.
Wani M, Afroze D, Makhdoomi M, Hamid I, Wani B, Bhat G, Wani R, Wani K (2012). “Promoter methylation status of DNA repair gene (hMLH1) in gastric carcinoma patients of the Kashmir valley”. 《Asian Pac. J. Cancer Prev.》 13 (8): 4177–81. doi:10.7314/APJCP.2012.13.8.4177. PMID23098428.
Lee KH, Lee JS, Nam JH, Choi C, Lee MC, Park CS, Juhng SW, Lee JH (October 2011). “Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence”. 《Langenbecks Arch Surg》 396 (7): 1017–26. doi:10.1007/s00423-011-0812-9. PMID21706233. S2CID8069716.
Mokarram P, Zamani M, Kavousipour S, Naghibalhossaini F, Irajie C, Moradi Sarabi M, 외. (May 2013). “Different patterns of DNA methylation of the two distinct O6-methylguanine-DNA methyltransferase (O6-MGMT) promoter regions in colorectal cancer”. 《Mol. Biol. Rep.》 40 (5): 3851–7. doi:10.1007/s11033-012-2465-3. PMID23271133. S2CID18733871.
Rubin H (March 2011). “Fields and field cancerization: the preneoplastic origins of cancer: asymptomatic hyperplastic fields are precursors of neoplasia, and their progression to tumors can be tracked by saturation density in culture”. 《BioEssays》 33 (3): 224–31. doi:10.1002/bies.201000067. PMID21254148. S2CID44981539.
Lee KH, Lee JS, Nam JH, Choi C, Lee MC, Park CS, Juhng SW, Lee JH (October 2011). “Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence”. 《Langenbecks Arch Surg》 396 (7): 1017–26. doi:10.1007/s00423-011-0812-9. PMID21706233. S2CID8069716.
Svrcek M, Buhard O, Colas C, Coulet F, Dumont S, Massaoudi I, 외. (November 2010). “Methylation tolerance due to an O6-methylguanine DNA methyltransferase (MGMT) field defect in the colonic mucosa: an initiating step in the development of mismatch repair-deficient colorectal cancers”. 《Gut》 59 (11): 1516–26. doi:10.1136/gut.2009.194787. PMID20947886. S2CID206950452.
Zuo C, Zhang H, Spencer HJ, Vural E, Suen JY, Schichman SA, Smoller BR, Kokoska MS, Fan CY (October 2009). “Increased microsatellite instability and epigenetic inactivation of the hMLH1 gene in head and neck squamous cell carcinoma”. 《Otolaryngol Head Neck Surg》 141 (4): 484–90. doi:10.1016/j.otohns.2009.07.007. PMID19786217. S2CID8357370.
umich.edu
open.umich.edu
Abrams, Gerald. “Neoplasia I”. 2015년 10월 31일에 원본 문서에서 보존된 문서. 2012년 1월 23일에 확인함.
Abrams, Gerald. “Neoplasia I”. 2015년 10월 31일에 원본 문서에서 보존된 문서. 2012년 1월 23일에 확인함.
“II Neoplasms”. 《International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10) Version for 2010》. World Health Organization. 2018년 7월 24일에 원본 문서에서 보존된 문서. 2014년 6월 19일에 확인함.
Abrams, Gerald. “Neoplasia I”. 2015년 10월 31일에 원본 문서에서 보존된 문서. 2012년 1월 23일에 확인함.
“II Neoplasms”. 《International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10) Version for 2010》. World Health Organization. 2018년 7월 24일에 원본 문서에서 보존된 문서. 2014년 6월 19일에 확인함.